Results 61 to 70 of about 5,485 (197)

Safe long-term therapy of Cushing’s syndrome over 37 years with mitotane

open access: yesFrontiers in Endocrinology
While suggested, surgery is not always possible as a first-line treatment of Cushing’s Disease (CD). In such cases, patients require medical therapy in order to prevent complications resulting from hypercortisolism.
Jonas Seibold   +3 more
doaj   +1 more source

The Treatment and Follow up of Adrenocortical Carcinoma [Adrenokortikal Karsinomlarda Tedavi Ve Izlem]

open access: yesMedicine Science, 2015
Adrenocortical carcinoma is a rare endocrine malignancy. Patients present with hormone excess or a local mass effect. The tumor is agressive and characterized by a high risk of recurrence even after complete resection. Recurrence rate (particularly local
Pinar Sisman, Canan Ersoy
doaj   +1 more source

Complete Radiological Response of Recurrent Metastatic Adrenocortical Carcinoma to Pembrolizumab and Mitotane

open access: yesClinical Medicine Insights: Oncology, 2021
Adrenocortical carcinoma (ACC) is a rare malignancy with a poor prognosis. Treatment options for ACC are limited, with resection the main intervention. Most cases present in late metastatic cases, and data regarding effective therapies is limited.
Walid Alam   +3 more
doaj   +1 more source

Corticotropinoma as a Component of Carney Complex. [PDF]

open access: yes, 2017
Known germline gene abnormalities cause one-fifth of the pituitary adenomas in children and adolescents, but, in contrast with other pituitary tumor types, the genetic causes of corticotropinomas are largely unknown.
Chittiboina, Prashant   +11 more
core   +2 more sources

The Concise Guide to PHARMACOLOGY 2025/26: Enzymes

open access: yesBritish Journal of Pharmacology, Volume 182, Issue S1, Page S307-S403, December 2025.
The Concise Guide to Pharmacology 2025/26 marks the seventh edition in this series of biennial publications in the British Journal of Pharmacology. Presented in landscape format, the guide provides a comparative overview of the pharmacology of drug target families. The concise nature of the Concise Guide refers to the style of presentation, being clear,
Stephen P. H. Alexander   +31 more
wiley   +1 more source

Role of Palliative Bronchial Stenting in Endobronchial Metastasis: An Atypical Case of Metastatic Adrenocortical Carcinoma in a Young Patient

open access: yesClinical Case Reports, Volume 13, Issue 10, October 2025.
Sequential bronchoscopic management of left main bronchus endobronchial metastasis. (A–B) Obstructive lesion visualized. (C) Post‐debulking lumen restored. (D) A 10×30 mm fully covered self‐expanding metal stent placed to maintain airway patency, resulting in improved ventilation and symptom relief.
Sushrut Ingawale   +4 more
wiley   +1 more source

Powder Self-Emulsifying Drug Delivery System for Mitotane: In Vitro and In Vivo Evaluation

open access: yesPharmaceutics
Drug Delivery Systems (DDSs) of known drugs are prominent candidates for new and more effective treatments of various diseases, as they may increase drug solubility, dissolution velocity, and bioavailability.
Mohamed Skiba   +6 more
doaj   +1 more source

Evaluation of 9-cis retinoic acid and mitotane as antitumoral agents in an adrenocortical xenograft model [PDF]

open access: yes, 2015
The available drug treatment options for adrenocortical carcinoma (ACC) are limited. In our previous studies, the in vitro activity of 9-cis retinoic acid (9-cisRA) on adrenocortical NCI-H295R cells was shown along with its antitumoral effects in a small
Baghy, Kornélia   +12 more
core  

Complications of Cushing's syndrome: state of the art [PDF]

open access: yes, 2016
Cushing's syndrome is a serious endocrine disease caused by chronic, autonomous, and excessive secretion of cortisol. The syndrome is associated with increased mortality and impaired quality of life because of the occurrence of comorbidities.
Biller, Beverly M. K   +5 more
core   +1 more source

Feminizing adrenocortical carcinoma with distant metastases: can surgery be considered? [PDF]

open access: yes, 2014
Functioning adrenocortical carcinomas are rare diseases with dismal prognosis. A 41-yearold man presenting with gynecomastia had a giant feminizing adrenocortical carcinoma at stage IV.
Fancellu, Alessandro   +2 more
core   +3 more sources

Home - About - Disclaimer - Privacy